BECTON, DICKINSON AND COMPANY Inventory Recall Expense
BECTON, DICKINSON AND COMPANY (BDX) reported Inventory Recall Expense of $98.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryRecallExpense · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY inventory recall expense for the quarter ending 2020-03-31 was $199.00M, a 206.15% increase year-over-year.
- BECTON, DICKINSON AND COMPANY inventory recall expense for the quarter ending 2019-12-31 was $59.00M.
- BECTON, DICKINSON AND COMPANY inventory recall expense for the quarter ending 2019-09-30 was $10.00M.
- BECTON, DICKINSON AND COMPANY inventory recall expense for the quarter ending 2019-06-30 was $65.00M.
- BECTON, DICKINSON AND COMPANY inventory recall expense for fiscal 2025 was $98.00M, a 157.89% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY inventory recall expense for fiscal 2024 was $38.00M, a 94.18% decline from fiscal 2023.
- BECTON, DICKINSON AND COMPANY inventory recall expense for fiscal 2023 was $653.00M, a 806.94% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY inventory recall expense for fiscal 2022 was $72.00M, a 28.57% increase from fiscal 2021.
| Period end | Inventory Recall Expense 3 month | Inventory Recall Expense 6 month | Inventory Recall Expense 9 month | Inventory Recall Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $98.00M 10-K · filed 2025-11-25 | |||
| 2024-09-30 | $38.00M 10-K · filed 2025-11-25 | |||
| 2023-09-30 | $653.00M 10-K · filed 2025-11-25 | |||
| 2022-09-30 | $72.00M 10-K · filed 2024-11-27 | |||
| 2021-09-30 | $56.00M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | $244.00M 10-K · filed 2020-11-25 | |||
| 2020-03-31 | $199.00M 10-Q · filed 2020-05-07 | $258.00M 10-Q · filed 2020-05-07 | $268.00M derived: sum of 3 quarters · filed 2021-02-04 | $333.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-12-31 | $59.00M 10-Q · filed 2021-02-04 | $69.00M derived: sum of 2 quarters · filed 2021-02-04 | $134.00M derived: sum of 3 quarters · filed 2021-02-04 | $199.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $75.00M derived: sum of 2 quarters · filed 2020-11-25 | $140.00M derived: sum of 3 quarters · filed 2020-11-25 | $75.00M 10-K · filed 2020-11-25 |
| 2019-06-30 | $65.00M 10-Q · filed 2020-08-06 | $130.00M derived: sum of 2 quarters · filed 2020-08-06 | $65.00M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $65.00M 10-Q · filed 2020-05-07 | $65.00M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |